FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Disopyramide Phosphate (Norpace) Capsules
Status: Resolved
»Duration of Shortage: 04/18/2014 - 02/12/2019
»Therapeutic Categories: Cardiovascular

Expand all

Pfizer Pharmaceuticals (Revised 02/12/2019)

Company Contact Information:
800-533-4535

Presentation
  • Norpace CR 100 mg Capsules; Bottle of 100 (NDC 0025-2732-31)
  • Norpace CR 150 mg Capsules; Bottle of 100 (NDC 0025-2742-31)
  • Norpace 100 mg Capsules; Bottle of 100 (NDC 0025-2752-31)
  • Norpace 150 mg Capsules; Bottle of 100 (NDC 0025-2762-31)
Note:
  • Available

Teva Pharmaceuticals (Revised 02/11/2019)

Company Contact Information:
800-545-8800

Presentation
  • Disopyramide phosphate 100 mg capsules, bottle of 100 (NDC 00093-3127-01)
  • Disopyramide phosphate 150 mg capsules, bottle of 100 (NDC 00093-3129-01)
Note:
  • Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English